Abstract: A modular membrane filtration system (5) includes a number of banks (6) of membrane modules (7). Each module (7) includes upper and lower modular manifolds (8) and (9), respectively which are connected to one another to form upper and lower common manifolds (10) and (11) for each bank (6). The upper and lower manifolds (8) and (9) are used for delivery of feed and removal of filtrate and waste liquid from the modules (7). A gas feed manifold (12) runs along the top of the module banks (6) and feeds gas to lower gas manifold (13) through drop lines (14). A further manifold (15) runs in parallel with the common upper and lower manifolds (10) and (11) and is connected thereto at connections points (16) between the manifold banks (6).

Abstract: Compositions, methods and kits useful for the diagnosis, prognosis, and treatment of renal cell cancer are provided.

Abstract: A compound of formula (I) (I) wherein R is H; Ar is an aromatic group selected from phenyl; X is a phenyl group; R? is H or C1-C4 alkyl; each R1 is independently H or C1-C4 alkyl; and pharmaceutically acceptable salts thereof

Abstract: A process relating to the production of energy from a stream comprising hydrogen sulfide to produce greatly increased quantities of energy.

Abstract: A portable fluid heating tool capable of heating a flow of water under mains pressure to about 107 degrees Celsius and has a connection to a water supply via a hose. Water flows through an electrical heater within the tool, then to a thermally controlled pressure regulating valve (80) and then to the outlet nozzle. This valve (80) has a moveable member such as a diaphragm (83) sealing off a pressure chamber (88). Movement of the diaphragm (83) causes a valve (85) to open or at least partly close. When closed the valve (85) impedes, or restricts the flow of water from an inlet (86) to an outlet (87) through the valve. On the other side of the diaphragm a small quantity of water is trapped within the pressure chamber (88), so that as the valve (80) heats up, pressure within the pressure chamber (88) rises as the water turns to water vapour and the air within the chamber also expands.

Abstract: The present invention is directed to a system and a method to unload bulk powders from large bulk containers. The system and method are particularly useful for unloading bulk cohesive powders.

Abstract: The present invention is directed to a system and a method to unload bulk powders from large bulk containers. The system and method are particularly useful for unloading bulk cohesive powders.

Abstract: Use of a compound of formula (I) in which, R1, R2 and R3 are independently hydrogen, (C1-C6)alkyl, (C2-C6)alkenyl, C3-C10)cycloalkyl, unsubstituted or substituted aryl, unsubstituted or substituted aryl(C1-C6)alkyl, unsubstituted or substituted aryl(C2-C6)alkenyl, halo, carboxy, (C1-C6)alkoxycarbonyl or —(CH2)m—OH wherein m is 1, 2 or 3; - - - indicates a single or a double bond; X and each independently hydrogen, or X and Y together represent a bridge of the formula —CH2)m—, where n is 1 or 2; A1 and A2 are each independently an unsubstituted or substituted aryl; Z is —CO—, —SO2— or —CH2; provided that, when Z is —CO—, A1 is not 3,4,5-trimethoxyphenyl; or a pharmaceutically-acceptable salt or ester thereof, for the manufacture of a medicament for the treatment of a condition indicating the administration of a selective mGluR1 antagonist.

Abstract: A liquid, radiation-curable coating suitable for coating thermoplastic substrates is described. The coating composition can be formulated to achieve very low gloss at both high and low angles of incidence, and is suitable for application to moldable thermoplastic sheet, and in particular is suitable for application to thermoplastic olefin moldable sheet. Such coatings are useful in protecting thermoplastic substrates and achieving a low-gloss surface in a wide variety of applications including automotive interior parts, furniture, and artificial leather articles.

Abstract: Compounds of the formula ##STR1## in which R.sup.1 is Y or Y--C.sub.1-6 alkyl, where Y is carboxy, tetrazolyl, --SO.sub.2 H, --SO.sub.3 H, --OSO.sub.3 H, --CONHOH, or --P(OH)OR', --PO(OH)OR', --OP(OH)OR' or --OPO(OH)OR' where R' is hydrogen, C.sub.1-6 alkyl, C.sub.2-6 alkenyl or optionally substituted phenyl-C.sub.1-6 alkyl,and R.sup.2, R.sup.3, R.sup.4, X and Z are as defined in the specification, possess affinity for metabotropic glutamate receptors and are useful in the treatment of disorders of the central nervous system.

Abstract: Disclosed is an aqueous dispersion of a transparent powder coating consisting of a solid powder component and an aqueous component. The solid powder component includes at least one epoxy group-containing binder, at least one crosslinking agent, and optionally catalysts, adjuvants, or additives typical for transparent powder coatings. The binder contains 30-45% glycidyl-containing monomers and optionally vinylaromatic compounds such as styrene. The crosslinking agent is preferably a straight-chain aliphatic dicarboxylic acid and/or a carboxy-functional polyester. The aqueous component includes at least one nonionic thickener and optional materials such as catalysts, adjuvants, and/or other such materials. The nonionic thickener is preferably a nonionic associative thickener. The invention also provides a process for preparing the aqueous dispersion of the invention and a process for coating a vehicle body with the aqueous dispersion of the invention.

Abstract: A pharmaceutical compound of the formula: ##STR1## in which A is carboxy, tetrazolyl, --SO.sub.2 H, --SO.sub.3 H, --OSO.sub.3 H, --CONHOH, or --P(OH)OR', --PO(OH)OR', --OPO(OH)OR'B is a bond, C.sub.1-6 alkylene or C.sub.2-6 alkenylene,R.sup.1 is hydrogen, hydroxyl, halo or group of the formula A--B--,X is C.sub.1-6 alkylene, C.sub.2-6 alkenylene, C.sub.2-6 alkynylene or C.sub.1-6 alkylene linked through --O--, --S-- or --NR"-- to Y, where R" is hydrogen or C.sub.1-6 alkyl,andY is (1) ##STR2## where p is and Z is ##STR3## or (2) ##STR4## and salts and esters thereof.

Abstract: A pharmaceutical compound of the formula: ##STR1## in which R.sup.1 is hydrogen, hydroxy or C.sub.1-6 alkoxy, R.sup.2 is hydrogen, carboxy, tetrazolyl, --SO.sub.2 H, --SO.sub.3 H, --OSO.sub.3 H, --CONHOH, or --P(OH)OR', --PO(OH)OR', --OP(OH)OR' or --OPO(OH)OR' where R' is hydrogen, C.sub.1-6 alkyl, C.sub.2-6 alkenyl or aryl C.sub.1-6 alkyl,R.sup.3 is hydrogen, hydroxy or C.sub.1-4 alkoxy, andR.sup.4 is fluoro, trifluoromethyl, nitro, C.sub.1-6 alkyl, C.sub.3-7 cycloalkyl, C.sub.2-6 alkenyl, C.sub.2-6 alkynyl, C.sub.1-6 alkylthio, heteroaryl, optionally substituted aryl, optionally substituted aryl C.sub.1-6 alkyl, optionally substituted aryl C.sub.2-6 alkenyl, optionally substituted aryl C.sub.2-6 alkynyl, optionally substituted aryloxy, optionally substituted aryl C.sub.1-6 alkoxy, optionally substituted arylthio, optionally substituted aryl C.sub.1-6 alkylthio or --CONR"R'", --SO.sub.2 NR"R"", --NR"R'", --OCONR"R"' or --SONR"R'" where R" and R'" are each hydrogen, C.sub.1-6 alkyl or aryl C.sub.

Abstract: An operating system for telescoping a telescopic boom for a crane, particularly a boom having three or more telescoping sections, enabling the boom to be extended and retracted automatically under load according to a predetermined sequence which optimises the load capacity of the boom and the stability of the crane. The boom may be switched rapidly between modes of operation in one of which all of the telescoping sections may extend or retract and in another of which at least one telescoping section is maintained in the fully retracted position.

Abstract: The feedback calculation for a dynamic matrix control (DMC) system has been modified so that it can accommodate a delay period between the time when the output variable is measured and when the measurement is available for feedback. This was accomplished by storing the projection vectors calculated by the DMC system and then comparing them to the output variable measurements as they become available. The algorithm was modified to handle planned production rate changes by adding another term to the equation used to calculate the projection vectors. This term involves multiplying the dynamic matrix for a given disturbance variable by a vector of future changes in that disturbance variable.

Abstract: Compounds are disclosed of formula (I): ##STR1## wherein one of R.sup.1, R.sup.2 and R.sup.3 represents hydrogen, C.sub.1-6 alkyl C.sub.3-6 alkenyl, hydroxy, C.sub.1-4 alkoxy or a C.sub.2-5 alkoxycarbonyl group, a phenyl or substituted phenyl group or a phen(C.sub.1-4)alkyl or substituted phen(C.sub.1-4)alkyl group; and the other two each independently represents hydrogen, C.sub.1-6 alkyl, or R.sup.2 and R.sup.3 together form an alkylene chain --(CH.sub.2).sub.n --where n is 2 or 3, bridging the nitrogen atoms to which they are attached; R.sup.4 and R.sup.5, each independently represents hydrogen, C.sub.1-3 alkyl or propenyl; R.sup.6 represents hydrogen, C.sub.1-3 alkyl, and the physiologically acceptable salts and solvates thereof.The compounds (I) have potent and selective vasoconstrictor activity and are potentially useful for the treatment of migraine. The compounds (I) may be formulated in conventional manner as pharmaceutical compositions for administration by any convenient route.